Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster viewing and lunch

267P - Ultrasound-Guided Injection With or Without Rehabilitation Exercise in Breast Cancer Survivors with Subacromial-Deltoid Bursitis: Long-Term Results of a Pilot Randomized Clinical Study

Date

12 May 2023

Session

Poster viewing and lunch

Presenters

Arianna Folli

Citation

Annals of Oncology (2023) 8 (1suppl_4): 101224-101224. 10.1016/esmoop/esmoop101224

Authors

L. Lippi1, A. de Sire2, A. Folli3, G. Massocco3, A. Maconi4, N. Fusco5, M. Invernizzi6

Author affiliations

  • 1 University of Eastern Piedmont "A. Avogadro, Novara/IT
  • 2 UMG - Università degli Studi Magna Graecia di Catanzaro, Catanzaro/IT
  • 3 University of Eastern Piedmont "A. Avogadro", Novara/IT
  • 4 Translational Medicine, Alessandria/IT
  • 5 IEO - Istituto Europeo di Oncologia, Milan/IT
  • 6 University of Eastern Piedmont "A. Avogadro", 28100 - Novara/IT

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract 267P

Background

Breast cancer (BC) survivors frequently complain of functional limitation of the shoulder following cancer treatments. Despite the physical and psychological implications, the optimal management of this disabling condition is still debated. Thus, the aim of this study was to assess the long-term effects of a comprehensive rehabilitation program, including ultrasound (US) guided injection of the sub-acromial deltoid bursa (SAD) combined with a physical rehabilitation protocol.

Methods

In this randomized controlled study, adult BC survivors with SAD bursitis were assessed for eligibility and randomly assigned to Group A and Group B. Both groups received corticosteroid US guided injection into the SAD bursa, while only Group A received 5 rehabilitation sessions, 1 hour each. Outcomes were assessed at baseline, after one week (T1), three months (T2), and six months (T3). It was assessed the Numerical Pain Rating Scale (NPRS), handgrip strength (HGS) test, European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30), the Oxford Shoulder Score (OSS), Global Perceived Effect (GPE), and safety.

Results

Thirty-seven women were randomly assigned to Group A (n=19; mean age: 56.05 ± 10.30 years) and Group B (n=18; mean age: 58.39 ± 12.09 years). No adverse events were reported. Statistically significant within-group differences were found in both groups in terms of NPRS at T1, T2, and T3 (p <0.05). The between-group analysis showed no differences (p > 0.05) at T1; however, at T2 significant differences were reported in terms of NPRS (2.16 ± 1.39 vs 4.78 ± 1.77; p <0.05), HGS (25.11 ± 3.20 vs 20.33 ± 4.92; p<0.001), OSS (17.00 ± 3.27 vs 33.11 ± 6.471; p<0.0001), and EORTC QLQ-C30 (Functional, Symptom and Global Health subscales, p<0.05). Furthermore, NPRS remained significantly lower in Group A compared to Group B (2.56 ± 1.05 vs 4.65 ± 1.13; p <0.05) at T3.

Conclusions

A comprehensive rehabilitation strategy including US guided injection and physical rehabilitation exercise may be considered safe, feasible, and effective for long-term management of SAD bursitis in BC patients.

Legal entity responsible for the study

The authors.

Funding

Has not received any funding.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.